GLOW-CRISPR: A G-Quadruplex Loop-Engineered Optical Workflow Combined with CRISPR-Cas12a System for SARS-CoV-2 Detection
Authors: Shi, Wenyang; Lin, Xiaodong; Li, Xiang; Pal, Tathagata; Liu, Benjamin M; Chen, Juhong
Source journal: Analytical chemistry (2026-11-17)
DOI: 10.1021/acs.analchem.6c05407
Abstract
SARS-CoV-2 remains a serious public health threat, highlighting the need for rapid and accessible nucleic-acid diagnostics for decentralized testing. CRISPR-Cas systems are promising platforms for viral diagnostics because of their high specificity and compatibility with isothermal workflows. However, many CRISPR-based assays still rely on labelled reporters, dedicated fluorescence instrumentation, or single-mode outputs that increase cost and limit field deployment. Herein, we developed a label-free GLOW-CRISPR assay (a G-quadruplex loop-engineered optical workflow combined with the CRISPR-Cas12a system) to detect SARS-CoV-2. The assay provides fluorescence and colorimetric readouts in separate endpoint workflows through loop-engineered G4 reporters. Upon recognition of the SARS-CoV-2 target, activated Cas12a cleaves the loop-engineered G4 reporters, thereby suppressing both fluorescence and colorimetric signals. Using optimized conditions, the GLOW-CRISPR assay achieved limits of detection of 7.7 nM and 2.9 nM for fluorescence and colorimetric readouts, respectively. It also showed no detectable cross-reactivity with non-target respiratory viruses and correctly classified patient-derived nasopharyngeal samples in concordance with RT-qPCR results. Collectively, these results establish G4 loop engineering as a general strategy for label-free CRISPR-Cas12a signal transduction without probe labelling or specialized instrumentation. By expanding optical readout flexibility while reducing assay cost and complexity, the GLOW-CRISPR assay provides a practical framework for decentralized molecular diagnostics in resource-limited settings.
Related topics
Related open access articles
- Assessment of Groundwater Quality Parameters in Northern Region of Zanzibar Island
- CHALLENGES IN THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH COLORECTAL CANCER AND COVID-19 COINFECTION - CASE REPORT
- Facing COVID-19 via anti-inflammatory mechanism of action: Molecular docking and Pharmacokinetic studies of six anti-inflammatory compounds derived from Passiflora edulis
- Computational analysis by molecular docking of thirty alkaloid compounds from medicinal plants as potent inhibitors of SARS-CoV-2 main protease
- The use of non-invasive ventilation (NIV) in the treatment of patients with COVID-19
- Application of Nanotechnology in Treatment of COVID-19
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.